1445787-27-8

Basic information

• Product Name: 3-((3-carbamoyl-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl)amino)-5-(methylcarbamoyl)benzoic acid
• Synonyms: 3-((3-carbamoyl-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl)amino)-5-(methylcarbamoyl)benzoic acid
• CAS NO: 1445787-27-8
• Molecular Weight: 502.486
• Mol File: 1445787-27-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-((3-carbamoyl-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl)amino)-5-(methylcarbamoyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-((3-carbamoyl-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl)amino)-5-(methylcarbamoyl)benzoic acid(1445787-27-8)
• EPA Substance Registry System: 3-((3-carbamoyl-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl)amino)-5-(methylcarbamoyl)benzoic acid(1445787-27-8)

Safety Data

• Hazardous Substances Data: 1445787-27-8(Hazardous Substances Data)

Upstream product

• 860205-92-1 7-bromo-4-hydroxy-3-quinolinecarboxylic acid 
• 1374867-81-8 7-bromo-4-chloroquinoline-3-carboxamide 
• 1374867-83-0 4-chloro-7-(2,4-dimethoxypyrimidin-5-yl)quinoline-3-carboxamide 
• 1954-96-7 3-amino-5-(methylcarbamoyl)benzoic acid 

Relevant articles and documents

CHEMICAL COMPOUNDS

The invention is directed to substituted quinoline derivatives. Specifically, the invention is directed to compounds according to Formula (I): wherein R1, R2, R3; R4; and R5 are defined herein. The compounds of the invention are inhibitors of lactate dehydrogenase A and can be useful in the treatment of cancer and diseases associated with tumor cell metabolism, such as cancer, and more specifically cancers of the breast, colon, prostate and lung. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting lactate dehydrogenase A activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.